targeted therapies
13 abstracts
Abstract
The role of neoadjuvant clinical trials in patients with newly diagnosed glioblastoma.Org: Johns Hopkins University Bloomberg School of Public Health, John Hopkins University,
Abstract
Multidimensional tumor profiling and its meaningful impact on personalized therapy outcomes: Insights from a real-world study.Org: Datar Cancer Genetics Europe GmbH,
Abstract
Improving ethnic and racial diversity within clinical trial populations through community recruitment and inclusion initiatives: Experience from MyTACTIC.Org: US Medical Affairs Oncology, Genentech, Inc.,
Abstract
The real-world impact of next-generation sequencing in advanced stages of solid tumor malignancies.Org: Orlando Health Cancer Institute, University of South Florida Morsani College of Medicine, Comprehensive Hematology-Oncology,
Abstract
First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting.Org: Ipsen Biopharmaceuticals,
Abstract
Electronic collection of cancer patient-reported outcomes using a novel digital oncology platform: A multi-site randomized controlled trial.Org: Vinehealth Digital Limited, Surrey Clinical Trials Unit, University of Surrey, Royal United Hospitals Bath NHS Foundation Trust, Hywel Dda University Health Board, Barking, Havering and Redbridge University Hospitals NHS Trust,
Abstract
Prediction of cancer treatment response from histopathology images through imputed transcriptomics.Org: Pangea Biomed, University of Pittsburgh, Pittsburgh, PA, Sheba Medical Center at Tel-Hashomer, University of Colorado School of Medicine, Department of Oncology and Cancer Research UK Cambridge Institute,
Abstract
Improved outcomes from reflex comprehensive genomic profiling-guided precision therapeutic selection across a major US healthcare system.Org: Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence Cancer Institute, Illumina, Inc., Health Research Accelerator, Providence Health/St John Cancer Institute,
Abstract
Comparison of response from RECIST1.1 and abstraction in real-world patients with lung cancer.Org: Genentech, Inc., Brigham and Women’s Hospital, Harvard Medical School, F. Hoffmann-La Roche Ltd,
Abstract
Delivery of precision oncology in advanced lung cancer: Gaps, barriers, and potential solutions.Org: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, Chapel Hill, NC, NC Translational and Clinical Sciences Institute, The University of North Carolina at Chapel Hill, University of North Carolina School of Public Health,
Abstract
Comparison of lung cancer clinical trials treatment options and standard practice in Brazilian National Health System over the last decade.Org: Sao Paulo State Cancer Institute (ICESP), Instituto do Câncer do Estado de São Paulo (ICESP), University of São Paulo/ICESP,
Abstract
Dermocosmetics in management of cancer-related skin toxicities: International expert consensus.Org: Nantes Université, University of Queensland Diamantina Institute, Hospital Alemao Oswaldo Cruz, Departments of Dermatology & Radiation Oncology, La-Roche Posay International,
Abstract
Real world early experience of precision neoadjuvant systemic therapy in patients with resectable NSCLC: Single institution experiences and perspectives.Org: University of California, Davis, UC Davis Comprehensive Cancer Center, Sacramento, CA,